Imagene AI provides AI-based molecular diagnosis for cancer, leveraging the patient's histological data for personalized therapy. Our mission is to assist cancer patients in receiving the optimal treatment medicine can offer by leveraging AI to detect, in real-time, a broad range of cancerous biomarkers and genomic insights from the biopsy image alone. By doing so, Imagene overcomes economical, logistical, and technological barriers to reach the full potential of precision medicine for cancer patients. Through collaborations with top-tier medical centers and pharmaceutical companies, Imagene is revolutionizing molecular screening for both clinical practice and research. Our success derives from our cutting-edge technology and talented multidisciplinary team of data scientists, biologists, software engineers, and medical experts. If you want to join us in our mission to create a true impact on cancer patients, we would like to hear from you.
B2B
1 to 25
N/A
N/A
Scaling Up
2020
Information Technology and Services
Biotechnology
H&E-Stained Biopsy Slide
Genomic Testing
Phenotypic Alterations
Increase Efficiency
Reduce Operational Cost
Analytics
Service
Yes
Active
Machine Learning
Natural Language Processing
Automated Planning and Search
Knowledge Representation and Reasoning
Software
Senior Data Scientist
Tel Aviv
Senior Full Stack Engineer
Tel Aviv
DevOps Engineer
Tel Aviv
Head of Science
Tel Aviv
Want to work at Imagene AI?
We can introduce you to the right person at Imagene AI
1
1
$3M
Company was founded 2020 and it took almost 2 years (May 2022) to raise first external round
Interested in researching Imagene AI?
We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Imagene AI
Dean Bitan
Chief Executive Officer
Jonathan Zalach
Co-Founder & Chief Data Scientist
Shahar Porat
Co-Founder & Chief Technology Officer
Efrat Rahat
VP of HR
Will Brown
Vice President , Head of Strategic Partnerships
Interested in what they do or partnership?
Learn more about how they work